Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 9-jild 2-son (2024)
RELEVANCE OF COVID-19 IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
ИМАМОВА Ильмира Абдуллаевна
Annotatsiya
In the study of patients with COVID-19, those with CVH (CCHF) had increased levels of proinflammatory cytokine/IL-6, medium molecular weight peptides, and C-reactive protein (CRP). These markers were found to be correlated with slow disease progression, prolonged persistence of symptoms, and unfavorable treatment outcomes. Administering high-molecular-weight heparin without establishing the presence of cardiovascular disease in a patient with COVID-19 and without studying hemostasis data can worsen the patient's condition due to the accelerated development of hypocoagulation on the background of thrombophilia. It has been established that the presence of obesity of II-III degree, pathologies related to the cardiovascular system, bronchial asthma, and diabetes mellitus in patients with COVID-19 contributes to a more severe course of the disease. The long-term preservation of an elevated level of C-reactive protein in patients with CCHF reflects ongoing tissue damage and prolongation of the severity of the inflammatory process. This can serve as a diagnostic and prognostic marker for the need for long-term rehabilitation.
хронические вирусные гепатиты, COVID-19., цитокина / ИЛ-6, гипокоагуляции, С-реактивного белка (СРБ)chronic viral hepatitis, COVID-19, cytokine/IL-6, hypocoagulation, C-reactive protein (CRP)surunkali virusli gepatit, COVID-19., sitokin / IL-6, C-reaktiv oqsil (CRP), gipokoagulya
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.